Biomea Fusion BMEA Stock
11.73 USD
{{ price }}
-1.841006%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
465.84M USD
LOW - HIGH [24H]
12.64
-
13.66 USD
VOLUME [24H]
123.53K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-3.44 USD
Biomea Fusion Price Chart
Biomea Fusion BMEA Financial and Trading Overview
| Biomea Fusion stock price | 11.73 USD |
| Previous Close | 38.9 USD |
| Open | 38.84 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 35.84 - 38.84 USD |
| 52 Week Range | 6.04 - 43.69 USD |
| Volume | 995.36K USD |
| Avg. Volume | 1.09M USD |
| Market Cap | 1.3B USD |
| Beta (5Y Monthly) | -1.055025 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.14 USD |
BMEA Valuation Measures
| Enterprise Value | 1.3B USD |
| Trailing P/E | N/A |
| Forward P/E | -9.818666 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 13.131242 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -13.522 |
Trading Information
Biomea Fusion Stock Price History
| Beta (5Y Monthly) | -1.055025 |
| 52-Week Change | 320.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 43.69 USD |
| 52 Week Low | 6.04 USD |
| 50-Day Moving Average | 32.07 USD |
| 200-Day Moving Average | 16.15 USD |
BMEA Share Statistics
| Avg. Volume (3 month) | 1.09M USD |
| Avg. Daily Volume (10-Days) | 894.53K USD |
| Shares Outstanding | 35.4M |
| Float | 21.62M |
| Short Ratio | 13.23 |
| % Held by Insiders | 27.42% |
| % Held by Institutions | 43.80% |
| Shares Short | 6.18M |
| Short % of Float | 32.34% |
| Short % of Shares Outstanding | 17.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.28% |
| Return on Equity (ttm) | -76.25% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -96447000 USD |
| Net Income Avi to Common (ttm) | -94513000 USD |
| Diluted EPS (ttm) | -3.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.3M USD |
| Total Cash Per Share (mrq) | 2.44 USD |
| Total Debt (mrq) | 13.35M USD |
| Total Debt/Equity (mrq) | 16.06 USD |
| Current Ratio (mrq) | 4.737 |
| Book Value Per Share (mrq) | 2.804 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -76467000 USD |
| Levered Free Cash Flow (ttm) | -44209624 USD |
Profile of Biomea Fusion
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 900 Middlefield Road |
| ZIP | 94063 |
| Phone | 650 980 9099 |
| Website | https://biomeafusion.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 86 |
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Q&A For Biomea Fusion Stock
What is a current BMEA stock price?
Biomea Fusion BMEA stock price today per share is 11.73 USD.
How to purchase Biomea Fusion stock?
You can buy BMEA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biomea Fusion?
The stock symbol or ticker of Biomea Fusion is BMEA.
Which industry does the Biomea Fusion company belong to?
The Biomea Fusion industry is Biotechnology.
How many shares does Biomea Fusion have in circulation?
The max supply of Biomea Fusion shares is 39.71M.
What is Biomea Fusion Price to Earnings Ratio (PE Ratio)?
Biomea Fusion PE Ratio is now.
What was Biomea Fusion earnings per share over the trailing 12 months (TTM)?
Biomea Fusion EPS is -3.44 USD over the trailing 12 months.
Which sector does the Biomea Fusion company belong to?
The Biomea Fusion sector is Healthcare.
Biomea Fusion BMEA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}